A detailed history of Us Bancorp \De\ transactions in Rx Sight, Inc. stock. As of the latest transaction made, Us Bancorp \De\ holds 80 shares of RXST stock, worth $3,712. This represents 0.0% of its overall portfolio holdings.

Number of Shares
80
Previous 212 62.26%
Holding current value
$3,712
Previous $12,000 75.0%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

SELL
$40.78 - $57.04 $5,382 - $7,529
-132 Reduced 62.26%
80 $3,000
Q2 2024

Aug 06, 2024

SELL
$50.42 - $64.29 $15,781 - $20,122
-313 Reduced 59.62%
212 $12,000
Q1 2024

May 07, 2024

BUY
$35.51 - $57.92 $3,551 - $5,792
100 Added 23.53%
525 $27,000
Q4 2023

Feb 09, 2024

BUY
$20.91 - $40.9 $8,886 - $17,382
425 New
425 $17,000

Others Institutions Holding RXST

About RxSight, Inc.


  • Ticker RXST
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 27,638,900
  • Market Cap $1.28B
  • Description
  • RxSight, Inc., a medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. T...
More about RXST
Track This Portfolio

Track Us Bancorp \De\ Portfolio

Follow Us Bancorp \De\ and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

News

Stay updated on Us Bancorp \De\ with notifications on news.